Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Study analyzes how the coronavirus spreads indoors

A new study from the University of Minnesota College of Science and Engineering analyzes how the coronavirus spreads indoors - information that could help businesses and schools take precautions to reduce the chance of COVID-19 transmission as they reopen.

28 Jul 2020

Ergonomic lessons from the 'new normal' of working from home

Taking a few minutes to get that periodic cup of joe might not be such a bad idea.

28 Jul 2020

Fighting a pandemic is 500 times more expensive than the costs of preventive efforts

According to new research, the failure to protect tropical rain forests has cost trillions of dollars stemming from the coronavirus pandemic, which has wreaked economic havoc and caused historic levels of unemployment in the United States and around the world.

28 Jul 2020

Evolutionary origins of SARS-CoV-2 identified

By reconstructing the evolutionary history of SARS-CoV-2, the virus that is responsible for the COVID-19 pandemic, an international research team of Chinese, European and U.S. scientists has discovered that the lineage that gave rise to the virus has been circulating in bats for decades and likely includes other viruses with the ability to infect humans.

28 Jul 2020

Pitt collaborative receives $7 million to evaluate convalescent plasma therapy for COVID-19

A team of University of Pittsburgh, Michigan Medicine, Medical University of South Carolina and Stanford Medicine. researchers recently were awarded funds from the National Heart, Lung, and Blood Institute in collaboration with the Biomedical Advanced Research and Development Authority, part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, totaling more than $7 million to collaboratively study the role of convalescent plasma in mitigating symptoms of COVID-19 in patients with mild illness and preventing the progression of the disease from mild to severe.

28 Jul 2020

Protein produced by the human immune system can strongly inhibit Sars-Cov-2

A protein produced by the human immune system can strongly inhibit corona viruses, including Sars-Cov-2, the pathogen causing Covid-19. An international team from Germany, Switzerland and the USA successfully showed that the LY6E-Protein prevents coronaviruses from causing an infection.

28 Jul 2020

The COVID-19 downturn triggers jump in Medicaid enrollment

Reversing a three-year decline, the number of people covered by Medicaid nationwide rose markedly this spring as the impact of the recession caused by the outbreak of COVID-19 began to take hold.

28 Jul 2020

Cat catches coronavirus from owners

Cases of pet animals contracting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been reported since the coronavirus disease (COVID-19) first emerged. Now, a pet cat has become the first animal in Britain to test positive after contracting the virus from its owners.

28 Jul 2020

Official counts of COVID-19 cases understate the number of people affected by coronavirus

In mid-April, as the COVID-19 epidemic roared through the nation, 2,017,105 jobholders were absent from work because they were ill.

28 Jul 2020

App for tracking COVID-19 symptoms may not be a good predictor of the spread of virus

A new piece in Family Practice, published by Oxford University Press, indicates that tracking symptoms affiliated with the novel coronavirus through an app may not be a good predictor of the spread of the disease.

28 Jul 2020

Moderna coronavirus vaccine candidate moves to phase 3 with 30,000 participants

The world’s most significant coronavirus disease (COVID-19) vaccine study is underway in the United States, with a planned 30,000 volunteers. The phase 3 clinical trial aims to examine the efficacy and safety of the candidate vaccine developed by the National Institutes of Health and Moderna Inc.

28 Jul 2020

Ethanol-based hand sanitizer can help fight the spread of coronavirus

Inside the Mizzou Asphalt Pavement and Innovation Lab at the University of Missouri College of Engineering, Bill Buttlar normally leads a research team developing innovative ways to build better roads and stronger bridges.

28 Jul 2020

Swiss study shows how critical time is in responding to COVID-19

A new study published on the preprint server medRxiv in July 2020 reveals the crucial nature of time as a factor in controlling the mortality rate in the current COVID-19 pandemic.

27 Jul 2020

MU School Of Nursing programs provide assistance to more than 500 nursing homes during COVID-19

As the coronavirus pandemic continues to put a strain on health care systems, nursing homes have become overburdened with the challenge of keeping both patients and staff safe and healthy.

27 Jul 2020

GW to participate in a clinical trial for investigational COVID-19 vaccine

The George Washington University today announced that it will participate in a clinical trial for an investigational COVID-19 vaccine.

27 Jul 2020

Low plasma vitamin D level appears to be an independent risk factor for COVID-19 infection

Vitamin D is recognized as an important co-factor in several physiological processes linked with bone and calcium metabolism, and also in diverse non-skeletal outcomes, including autoimmune diseases, cardiovascular diseases, type 2 diabetes, obesity and cognitive decline, and infections.

27 Jul 2020

Yale and AI Therapeutics launch clinical trial of potential COVID-19 drug

Yale School of Medicine and the biopharmaceutical firm AI Therapeutics have launched a multi-institutional clinical trial of a drug for treating COVID-19.

27 Jul 2020

Brigham to play two key roles in phase 3 trial of COVID-19 vaccine candidate

A vaccine candidate for preventing COVID-19 is advancing to a 30,000-participant phase 3 trial that begins today, and Brigham and Women's Hospital will play two key roles in the trial's next phase.

27 Jul 2020

Alternative amplification technique could accelerate COVID-19 testing

An alternative amplification technique to detect SARS-CoV-2 RNA could offer a way to rapidly test large numbers of people for COVID-19, although the technique is not as sensitive as quantitative RT-PCR, the current standard method for COVID-19 testing.

27 Jul 2020

AI Therapeutics announces start of Phase II clinical trial of potential COVID-19 treatment

AI Therapeutics announced the start of Phase II clinical trial for the treatment of newly diagnosed COVID-19 patients in collaboration with Yale University.

27 Jul 2020

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Study analyzes how the coronavirus spreads indoors

Ergonomic lessons from the 'new normal' of working from home

Fighting a pandemic is 500 times more expensive than the costs of preventive efforts

Evolutionary origins of SARS-CoV-2 identified

Pitt collaborative receives $7 million to evaluate convalescent plasma therapy for COVID-19

Protein produced by the human immune system can strongly inhibit Sars-Cov-2

The COVID-19 downturn triggers jump in Medicaid enrollment

Cat catches coronavirus from owners

Official counts of COVID-19 cases understate the number of people affected by coronavirus

App for tracking COVID-19 symptoms may not be a good predictor of the spread of virus

Moderna coronavirus vaccine candidate moves to phase 3 with 30,000 participants

Ethanol-based hand sanitizer can help fight the spread of coronavirus

Swiss study shows how critical time is in responding to COVID-19

MU School Of Nursing programs provide assistance to more than 500 nursing homes during COVID-19

GW to participate in a clinical trial for investigational COVID-19 vaccine

Low plasma vitamin D level appears to be an independent risk factor for COVID-19 infection

Yale and AI Therapeutics launch clinical trial of potential COVID-19 drug

Brigham to play two key roles in phase 3 trial of COVID-19 vaccine candidate

Alternative amplification technique could accelerate COVID-19 testing

AI Therapeutics announces start of Phase II clinical trial of potential COVID-19 treatment

Industry Focus eBook - Infectious Diseases (1st Edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Industry Focus eBook - Infectious Diseases (1st Edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in